Lead Capital Partners and Petra Capital Partners Make Platform Investment in Lieberman

Img
Professional Services Agriculture Natural Resources Veterinary Stem Cells Medical Supplies FDA Managed Care Diabetes Pharmaceutical Sports Medical Dev

Lead Capital Partners and Petra Capital Partners Make Platform Investment in Lieberman

Brenna Thomson
Vice President of Business Development
Lead Capital Partners
(615) 545 3133
bthomson@leadcp.com

Lead Capital Partners, LLC (“LCP”), a healthcare-focused private equity firm specializing in the lower middle market, announced a strategic investment in Lieberman, Inc. (“Lieberman” or the “Company”), in collaboration with the Company’s owners and management team. This transaction represents the second platform investment from LCP Fund II.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250130662477/en/

Founded in 1981, Lieberman is a premier primary market research and analytics firm serving a diverse client base, with particular expertise in the pharmaceutical, healthcare, and consumer industries. Through direct engagement with physicians, patients, and customers, Lieberman conducts both quantitative and qualitative research. Leveraging proprietary tools and methodologies, the Company delivers tailored insights in areas such as attitude and usage tracking, brand health, brand positioning, competitive intelligence, patient journey mapping, product and pricing strategy, and market segmentation. Lieberman will continue to be led by its existing management team.

“Partnering with LCP represents a transformative opportunity for Lieberman,” said Karl LiVigni, Partner at Lieberman. “We’ve found in LCP a partner deeply aligned with our culture and values, and their proven expertise in building enduring partnerships will enable us to scale while maintaining our commitment to delivering exceptional services to our clients.”

“We are thrilled to collaborate with Lieberman as it continues to strengthen its leadership in primary market research,” said Pryor Smartt, Managing Partner at Lead Capital Partners. “Lieberman’s reputation for delivering insightful, data-driven solutions empowers organizations to make well-informed decisions in product development and marketing. We are excited to support the Company’s growth and ongoing success in the years ahead.”

About Lieberman

Founded in 1981, Lieberman is an innovative, rapidly growing custom market research firm serving a variety of industries worldwide, with a particular focus on healthcare and a dedicated consumer division, FRC Research (acquired by Lieberman in 2016). Over four decades, the Company has built long-standing relationships with blue-chip clients by combining advanced quantitative analysis with nuanced qualitative methodologies, all led by integrated research teams. Leveraging cutting-edge technology and deep expertise, Lieberman delivers actionable insights into consumer behavior, market trends and competitive landscapes. For more information, please visit www.liebermanresearch.com.

About Lead Capital Partners

Lead Capital Partners is a lower middle market private equity firm focused on investing in healthcare services companies. LCP seeks to partner with founders and build enterprise value by leveraging its capital resources, operating experience and industry network. With 40+ years of investing experience, LCP's principals are singularly focused on unlocking the potential in premier small businesses across healthcare subsectors. LCP is based in Nashville, Tennessee. For more information, please visit www.leadcp.com.

About Petra Capital Partners

Petra Capital Partners is a private equity firm engaged in providing growth capital for companies located throughout the United States. Petra’s investment team has an established track record of success spanning over 25 years and deploying more than $900 million of capital invested into more than 100 high growth companies. Petra is actively seeking investments for its current SBIC fund, Petra Growth Fund V. Petra can invest up to $25 million per company in equity or debt securities with a primary focus on backing high growth business services, tech-enabled services and healthcare services companies. For more information, please visit www.petracapital.com.